« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 12, Issue 2
, Pages
172-183
, February 2006
Nonmyeloablative Stem Cell Transplantation Is an Effective Therapy for Refractory or Relapsed Hodgkin Lymphoma: Results of a Spanish Prospective Cooperative Protocol
-
Relationship between progression-free survival (PFS) and patients developing extensive chronic graft-versus-host disease (cGVHD) after transplantation.
Relationship between progression-free survival (PFS) and patients developing extensive chronic graft-versus-host disease (cGVHD) after transplantation.
-
Differences in overall survival (OS) (A), event-free survival (EFS) (B), and progression-free survival (PFS) (C) between chemosensitive (n = 20) and chemorefractory (n = 20) patients.
Differences in overall survival (OS) (A), event-free survival (EFS) (B), and progression-free survival (PFS) (C) between chemosensitive (n = 20) and chemorefractory (n = 20) patients.
-
Allo-RIC in patients who had a previously failed ASCT. Differences in overall survival (OS) (A), event-free survival (EFS) (B), and progression-free survival (PFS) (C) are shown between late (n = 10)
Allo-RIC in patients who had a previously failed ASCT. Differences in overall survival (OS) (A), event-free survival (EFS) (B), and progression-free survival (PFS) (C) are shown between late (n = 10) and early (n = 19) relapses.
PII: S1083-8791(05)00673-7
doi: 10.1016/j.bbmt.2005.09.009
© 2006 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 12, Issue 2
, Pages
172-183
, February 2006
